LukeGilbert
@lukegilbertsf
Core Investigator at Arc Institute and Associate Professor at UCSF
ID: 1131286370842845184
22-05-2019 19:51:03
27 Tweet
1,1K Takipçi
124 Takip Edilen
Delighted to announce I will be joining Arc! So excited to be working with Silvana Konermann Patrick Hsu SafePal - Crypto Wallet
Excited to share our work identifying IFITM proteins as key for cellular uptake of large drugs that break standard drug design rules! Hope it leads to new drug designs! This was a wonderful collaboration with Kevan Shokat led by Kevin Lou @ucsf Arc Institute science.org/doi/10.1126/sc…
Excited to share our work on how environmental perturbation rewires functional connection between human genes. @ucsf Arc Institute doi.org/10.1101/2023.0…
In vivo perturb-seq in cancer and immune cells with John Liu, MD PhD and RaleighLab. doi.org/10.1101/2023.0… Excited for this kind of approach in adult tissues and diseases! Arc Institute UC San Francisco
excited about multiAsCas12a which we (Chris Hsiung 熊) show enables 6plex CRISPRi functional genomics experiments Arc Institute @ucsf doi.org/10.1101/2023.0…
Excited to share our (with LukeGilbert) new preprint (is.gd/5kgWsI) on a new combinatorial functional genomics platform that enables 6-plex CRISPRi pooled screens. This platform works for multi-gene targeting and is especially suited for multi-enhancer targeting.
We’re thrilled to welcome Hani Goodarzi Hani Goodarzi, Associate Professor of Biochemistry & Biophysics UC San Francisco, as our newest Core Investigator His groundbreaking research uses machine learning models and experimental frameworks to dig into cancer progression and metastasis.
Jingtian Zhou joins as our first Science Fellow. Jingtian is a recent PhD graduate in Bioinformatics & Systems Biology from UC San Diego and a former Salk Institute scientist. His pioneering work has developed new algorithms and insights into the epigenetic basis of brain development
This week, Myllia Biotechnology welcomed LukeGilbert from the UC San Francisco and Christoph Bock from the Christoph Bock Lab @ CeMM & MedUni Vienna at CeMM for the annual SAB meeting in Vienna, Austria! The day was focused on Myllia’s technology platform combining CRISPR perturbation with single-cell RNA sequencing.
We’re honored to be on the Endpoints News #Endpoints11 2023 list of the most promising biotechs alongside an outstanding group of peers at the forefront of drug development. Cheers to our world-class cofounders, investors and partners, and dedicated team. More: chromamedicine.com/2023/09/21/chr…
🛠️New CRISPRi tool in Nature Biotechnology from LukeGilbert + lab! Until now, scientists have been limited to targeting fewer than 3 genes at a time with CRISPRi. But what about when we want to study more complex combinatorial biology?👇
Happy to report our platform for functional interrogation of cancer and microenvironment cells! Another step toward better treatments for glioblastoma. genomebiology.biomedcentral.com/articles/10.11… LukeGilbert RaleighLab Arc Institute UCSF Neurosurgery
excited to share COMET! A scalable CRISPR approach we (Caroline Wilson) developed to identify multidomain proteins that modulate transcription at specific endogenous genomic loci. Arc Institute @ucsf doi.org/10.1101/2024.1…
In collaboration with Reuben Saunders, Jonathan Weissman's Lab, and Xiaowei Zhuang, we are very excited to release Perturb-Multi: a platform for pooled multimodal genetic screens in intact mammalian tissue. Check it out! biorxiv.org/content/10.110…
Today, Arc announced it is joining forces with NVIDIA Healthcare to develop powerful computational tools that will help researchers everywhere explore and understand living systems in ways previously impossible. arcinstitute.org/news/news/arc-…